442 related articles for article (PubMed ID: 32222331)
1. Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015.
Eda R; Nakamura M; Takayama Y; Maehana S; Nakano R; Yano H; Kitasato H
J Infect Chemother; 2020 Jul; 26(7):667-671. PubMed ID: 32222331
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
Kim SH; Kim GR; Jeong J; Kim S; Shin JH
Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Genomic Characterization of Carbapenemase-producing Enterobacteriaceae (CPE) Reveals Changing Pattern of CPE Isolated in Hong Kong Hospitals.
Zhu C; Li C; Lai CKC; Ng R; Chau KY; Wong KT; Lo NWS; Barua N; Yang Y; Liyanapathirana V; Hui M; Lai RW; Fung KSC; Tsang DN; Ip M
Int J Antimicrob Agents; 2021 Nov; 58(5):106430. PubMed ID: 34525401
[TBL] [Abstract][Full Text] [Related]
4. Microbial infection pattern, pathogenic features and resistance mechanism of carbapenem-resistant Gram negative bacilli during long-term hospitalization.
Wen S; Feng D; Lu Z; Liu J; Peters BM; Tang H; Su D; Lin YP; Yang L; Xu Z; Shirtliff ME; Chen D
Microb Pathog; 2018 Apr; 117():356-360. PubMed ID: 29452198
[TBL] [Abstract][Full Text] [Related]
5. Molecular and microbiological report of a hospital outbreak of NDM-1-carrying Enterobacteriaceae in Mexico.
Bocanegra-Ibarias P; Garza-González E; Morfín-Otero R; Barrios H; Villarreal-Treviño L; Rodríguez-Noriega E; Garza-Ramos U; Petersen-Morfin S; Silva-Sanchez J
PLoS One; 2017; 12(6):e0179651. PubMed ID: 28636666
[TBL] [Abstract][Full Text] [Related]
6. Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.
Boonyasiri A; Jauneikaite E; Brinkac LM; Greco C; Lerdlamyong K; Tangkoskul T; Nguyen K; Thamlikitkul V; Fouts DE
BMC Infect Dis; 2021 Feb; 21(1):142. PubMed ID: 33541274
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
Yan L; Sun J; Xu X; Huang S
Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
[TBL] [Abstract][Full Text] [Related]
8. Spreading Patterns of NDM-Producing
Sugawara Y; Akeda Y; Hagiya H; Sakamoto N; Takeuchi D; Shanmugakani RK; Motooka D; Nishi I; Zin KN; Aye MM; Myint T; Tomono K; Hamada S
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30530602
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of multidrug-resistant Enterobacteriaceae in Sri Lanka: First evidence of bla
Kumudunie WGM; Wijesooriya LI; Namalie KD; Sunil-Chandra NP; Wijayasinghe YS
J Infect Public Health; 2020 Sep; 13(9):1330-1335. PubMed ID: 32439355
[TBL] [Abstract][Full Text] [Related]
10. Lateral dissemination and inter-patient transmission of blaKPC-3: role of a conjugative plasmid in spreading carbapenem resistance.
Tijet N; Muller MP; Matukas LM; Khan A; Patel SN; Melano RG
J Antimicrob Chemother; 2016 Feb; 71(2):344-7. PubMed ID: 26518052
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
Alsharapy SA; Gharout-Sait A; Muggeo A; Guillard T; Cholley P; Brasme L; Bertrand X; Moghram GS; Touati A; De Champs C
Microb Drug Resist; 2020 Mar; 26(3):211-217. PubMed ID: 31397629
[No Abstract] [Full Text] [Related]
12. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.
van der Zwaluw K; Witteveen S; Wielders L; van Santen M; Landman F; de Haan A; Schouls LM; Bosch T;
Clin Microbiol Infect; 2020 Oct; 26(10):1412.e7-1412.e12. PubMed ID: 32006688
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
[TBL] [Abstract][Full Text] [Related]
14. Circulation of
Venditti C; Fortini D; Villa L; Vulcano A; D'Arezzo S; Capone A; Petrosillo N; Nisii C; Carattoli A; Di Caro A
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559268
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Carbapenemase-Producing Enterobacteriaceae from Patients in Amman, Jordan.
Aqel AA; Findlay J; Al-Maayteh M; Al-Kaabneh A; Hopkins KL; Alzoubi H; Masalha I; Turton J; Woodford N; Ellington MJ
Microb Drug Resist; 2018 Oct; 24(8):1121-1127. PubMed ID: 29653473
[TBL] [Abstract][Full Text] [Related]
16. Carbapenemase-Producing Enterobacteriaceae and Nonfermentative Bacteria, the Philippines, 2013-2016.
Velasco JM; Valderama MT; Peacock T; Warawadee N; Nogrado K; Navarro FC; Chua D; Apichai S; Sirigade R; Macareo LR; Swierczewski B
Emerg Infect Dis; 2017 Sep; 23(9):1597-1598. PubMed ID: 28820383
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae in a Tunisian Hospital.
Ben Helal R; Dziri R; Chedly M; Klibi N; Barguellil F; El Asli MS; Ben Moussa M
Microb Drug Resist; 2018 Nov; 24(9):1361-1367. PubMed ID: 29596032
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.
Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516
[TBL] [Abstract][Full Text] [Related]
19. Use of WGS data for investigation of a long-term NDM-1-producing Citrobacter freundii outbreak and secondary in vivo spread of blaNDM-1 to Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
Hammerum AM; Hansen F; Nielsen HL; Jakobsen L; Stegger M; Andersen PS; Jensen P; Nielsen TK; Hansen LH; Hasman H; Fuglsang-Damgaard D
J Antimicrob Chemother; 2016 Nov; 71(11):3117-3124. PubMed ID: 27494919
[TBL] [Abstract][Full Text] [Related]
20. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
García-Castillo M; García-Fernández S; Gómez-Gil R; Pitart C; Oviaño M; Gracia-Ahufinger I; Díaz-Regañón J; Tato M; Cantón R;
Int J Antimicrob Agents; 2018 Mar; 51(3):511-515. PubMed ID: 29371104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
